Table 3 Pathways affected by hypermethylation of genes in cloned relative to IVF at 2-cell, 8-cell and blastocyst stage embryos.
Pathways affected by hypermethylation | No. of genes | P value | FDR |
---|---|---|---|
2-cell stage | |||
Integrin signalling pathway (P00034) | 162 | 7.13E−05 | 5.95E−03 |
Inflammation mediated by chemokine and cytokine signaling pathway (P00031) | 197 | 5.62E−04 | 3.13E−02 |
Gonadotropin-releasing hormone receptor pathway (P06664) | 193 | 8.59E−04 | 3.59E−02 |
PDGF signaling pathway (P00047) | 120 | 2.15E−03 | 7.20E−02 |
CCKR signaling map (P06959) | 140 | 2.28E−03 | 6.35E−02 |
Endothelin signaling pathway (P00019) | 73 | 4.51E−03 | 1.08E−01 |
Apoptosis signaling pathway (P00006) | 106 | 5.45E−03 | 1.14E−01 |
Ras Pathway (P04393) | 62 | 1.13E−02 | 2.10E−01 |
Angiogenesis (P00005) | 129 | 1.36E−02 | 2.27E−01 |
Wnt signaling pathway (P00057) | 200 | 1.56E−02 | 2.36E−01 |
T cell activation (P00053) | 72 | 2.19E−02 | 3.04E−01 |
EGF receptor signaling pathway (P00018) | 111 | 2.35E−02 | 3.02E−01 |
B cell activation (P00010) | 58 | 2.63E−02 | 3.14E−01 |
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway (P00027) | 91 | 3.82E−02 | 4.25E−01 |
Histamine H1 receptor mediated signaling pathway (P04385) | 39 | 3.90E−02 | 4.07E−01 |
8-cell stage | |||
Angiogenesis (P00005) | 165 | 4.38E−04 | 3.65E−02 |
Integrin signalling pathway (P00034) | 177 | 5.97E−04 | 3.33E−02 |
PDGF signaling pathway (P00047) | 139 | 1.99E−03 | 8.32E−02 |
CCKR signaling map (P06959) | 158 | 4.36E−03 | 1.46E−01 |
Wnt signaling pathway (P00057) | 236 | 8.09E−03 | 2.25E−01 |
Gonadotropin-releasing hormone receptor pathway (P06664) | 207 | 1.27E−02 | 3.02E−01 |
Alzheimer diseasE−presenilin pathway (P00004) | 110 | 1.59E−02 | 3.32E−01 |
Ras Pathway (P04393) | 69 | 1.98E−02 | 3.67E−01 |
EGF receptor signaling pathway (P00018) | 127 | 3.11E−02 | 5.19E−01 |
Endothelin signaling pathway (P00019) | 76 | 3.49E−02 | 5.30E−01 |
Apoptosis signaling pathway (P00006) | 113 | 3.63E−02 | 5.05E−01 |
Oxytocin receptor mediated signaling pathway (P04391) | 59 | 4.03E−02 | 5.17E−01 |
PI3 kinase pathway (P00048) | 56 | 4.48E−02 | 5.34E−01 |
Oxidative stress response (P00046) | 56 | 4.48E−02 | 4.99E−01 |
5HT2 type receptor mediated signaling pathway (P04374) | 67 | 4.72E−02 | 4.93E−01 |
Blastocyst stage | |||
Inflammation mediated by chemokine and cytokine signaling pathway (P00031) | 156 | 8.20E−05 | 6.85E−03 |
Wnt signaling pathway (P00057) | 168 | 2.71E−04 | 1.51E−02 |
Endothelin signaling pathway (P00019) | 62 | 4.57E−04 | 1.91E−02 |
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway (P00027) | 83 | 4.92E−04 | 1.64E−02 |
Integrin signalling pathway (P00034) | 115 | 9.68E−04 | 2.69E−02 |
Blood coagulation (P00011) | 44 | 2.10E−03 | 5.00E−02 |
Nicotinic acetylcholine receptor signaling pathway (P00044) | 66 | 2.52E−03 | 5.25E−02 |
PDGF signaling pathway (P00047) | 90 | 3.24E−03 | 6.02E−02 |
Angiogenesis (P00005) | 102 | 4.10E−03 | 6.85E−02 |
DNA replication (P00017) | 4 | 5.33E−03 | 8.09E−02 |
Ionotropic glutamate receptor pathway (P00037) | 39 | 5.61E−03 | 7.81E−02 |
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway (P00026) | 99 | 7.23E−03 | 9.29E−02 |
Alzheimer diseasE−amyloid secretase pathway (P00003) | 45 | 8.11E−03 | 9.67E−02 |
EGF receptor signaling pathway (P00018) | 86 | 1.19E−02 | 1.32E−01 |
Nicotine pharmacodynamics pathway (P06587) | 28 | 1.28E−02 | 1.34E−01 |
Gonadotropin-releasing hormone receptor pathway (P06664) | 134 | 1.31E−02 | 1.29E−01 |
Metabotropic glutamate receptor group I pathway (P00041) | 21 | 1.37E−02 | 1.27E−01 |
Alzheimer disease-presenilin pathway (P00004) | 73 | 1.44E−02 | 1.27E−01 |
Histamine H1 receptor mediated signaling pathway (P04385) | 32 | 1.57E−02 | 1.31E−01 |
Metabotropic glutamate receptor group III pathway (P00039) | 46 | 1.98E−02 | 1.58E−01 |
Cadherin signaling pathway (P00012) | 70 | 3.19E−02 | 2.42E−01 |
5HT2 type receptor mediated signaling pathway (P04374) | 45 | 3.34E−02 | 2.42E−01 |
Axon guidance mediated by netrin (P00009) | 26 | 3.51E−02 | 2.44E−01 |
Oxytocin receptor mediated signaling pathway (P04391) | 39 | 3.64E−02 | 2.43E−01 |
Insulin/IGF pathway-protein kinase B signaling cascade (P00033) | 27 | 4.45E−02 | 2.86E−01 |
B cell activation (P00010) | 42 | 4.73E−02 | 2.92E−01 |
Plasminogen activating cascade (P00050) | 17 | 4.94E−02 | 2.95E−01 |